Literature DB >> 8917554

Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses.

M Otsuji1, Y Kimura, T Aoe, Y Okamoto, T Saito.   

Abstract

One of the important mechanisms of immunosuppression in the tumor-bearing status has been attributed to the down-modulation of the CD3 zeta chain and its associated signaling molecules in T cells. Thus, the mechanism of the disappearance of CD3 zeta was investigated in tumor-bearing mice (TBM). The decrease of CD3 zeta was observed both in the cell lysate and intact cells. Direct interaction of T cells with macrophages from TBM (TBM-macrophages) induced the decrease of CD3 zeta, and depletion of macrophages rapidly restored the CD3 zeta expression. We found that treatment of such macrophages with N-acetylcysteine, known as antioxidant compound, prevented the decrease of CD3 zeta. Consistent with this result, the addition of oxidative reagents such as hydrogen peroxide and diamide induced the decrease of CD3 zeta expression in T cells. Consequently, the loss of CD3 zeta resulted in suppression of the antigen-specific T-cell response. These results demonstrate that oxidative stress by macrophages in tumor-bearing status induces abnormality of the T-cell receptor complex by cell interactions with T cells. Therefore, our findings suggest that oxidative stress contributes to the regulation of the expression and function of the T-cell receptor complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917554      PMCID: PMC24056          DOI: 10.1073/pnas.93.23.13119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.

Authors:  G A Watson; D M Lopez
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

2.  Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells.

Authors:  S Ono; H Ohno; T Saito
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

3.  Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice.

Authors:  J L Franco; P Ghosh; R H Wiltrout; C R Carter; A H Zea; N Momozaki; A C Ochoa; D L Longo; T J Sayers; K L Komschlies
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

4.  N-acetylcysteine-promoted survival of PC12 cells is glutathione-independent but transcription-dependent.

Authors:  C Y Yan; G Ferrari; L A Greene
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

5.  Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation.

Authors:  L H Elson; T B Nutman; D D Metcalfe; C Prussin
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

6.  Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.

Authors:  M R Young; M A Wright; J P Matthews; I Malik; M Prechel
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

7.  Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.

Authors:  M Matsuda; M Petersson; R Lenkei; J L Taupin; I Magnusson; H Mellstedt; P Anderson; R Kiessling
Journal:  Int J Cancer       Date:  1995-06-09       Impact factor: 7.396

8.  Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.

Authors:  D G Alleva; K D Elgert
Journal:  Immunobiology       Date:  1995-02       Impact factor: 3.144

9.  Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex.

Authors:  T Aoe; Y Okamoto; T Saito
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

10.  T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.

Authors:  D L Levey; P K Srivastava
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  77 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 2.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 3.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 4.  Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Semin Cancer Biol       Date:  2012-01-31       Impact factor: 15.707

5.  A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

Authors:  Samantha Solito; Erika Falisi; Claudia Marcela Diaz-Montero; Andrea Doni; Laura Pinton; Antonio Rosato; Samuela Francescato; Giuseppe Basso; Paola Zanovello; Georgiana Onicescu; Elizabeth Garrett-Mayer; Alberto J Montero; Vincenzo Bronte; Susanna Mandruzzato
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

6.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales.

Authors:  Gregory T Motz; George Coukos
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

7.  A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methods.

Authors:  A M Deakin; K Singh; J S Crowe; J H Ellis; A Dalgleish; R J Leicester; C J Finlayson; W F Miles; P F Life
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 8.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 9.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer.

Authors:  Nazita Yousefieh; Suzanne M Hahto; Amber L Stephens; Richard P Ciavarra
Journal:  Cancer Microenviron       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.